person · Reporting owner
Killian Christopher Moore
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | SVP, CTO & Sust. Ofc, | February 20, 2025 | February 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 20, 2025 · Filed February 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $100.56 · Expires 2035-02-19 | Direct | 18,508 |
Reported balance
After 2025-02-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-20 · Grant · Acquired 18,508 · Balance 18,508 F1: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,535 |
Reported balance
After 2025-02-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-20 · Grant · Acquired 3,535 · Balance 3,535 F2: Each restricted stock unit represents a contingent right to receive one share of issue common stock. F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of issue common stock.
F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2025 Filed Feb 24, 2025 21:19 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 3,535 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000044 · wk-form4_1740431953.xml · derivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP, CTO & Sust. Ofc, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,535 Underlying: Common Stock · 3,535 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issue common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:19 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 18,508 | $0.00 Strike: $100.56 | $0.00 |
DisclosureSEC source: 0000915389-25-000044 · wk-form4_1740431953.xml · derivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP, CTO & Sust. Ofc, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,508 Underlying: Common Stock · 18,508 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 3,210 | $103.47 | $332,138.70 |
DisclosureSEC source: 0000915389-25-000026 · wk-form4_1740085495.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP, CTO & Sust. Ofc, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,038 F3 · shares: Shares of common stock withheld in payment of tax liability incident to payout of performance shares. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 11,767 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000026 · wk-form4_1740085495.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP, CTO & Sust. Ofc, 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,248 F1 · shares: Payout of performance shares awarded at beginning of three-year (2022-2024) performance period. F2 · balance_after: Includes 115 units credited since November 6, 2024 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 21:12 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 3,061 | $105.00 | $321,405.00 |
DisclosureSEC source: 0000915389-24-000229 · wk-form4_1731013903.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,366 F1 · kind: The stock sale reported in this Form 4 was executed pursuant to a Rule 10b5-1 trading plan entered into by the reporting person and his broker August 6, 2024. F2 · balance_after: Includes 363 units credited since February 14, 2024 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 3,272 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000080 · wk-form4_1709240585.xml · derivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,272 Underlying: Common Stock · 3,272 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 27, 2027, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 27, 2027, subject to continued employment. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 16,165 | $0.00 Strike: $86.15 | $0.00 |
DisclosureSEC source: 0000915389-24-000080 · wk-form4_1709240585.xml · derivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,165 Underlying: Common Stock · 16,165 shares Expires 2034-02-26 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 27, 2025, February 27, 2026, and February 27, 2027, respectively. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:34 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 544 | $82.12 | $44,673.28 |
DisclosureSEC source: 0000915389-24-000043 · wk-form4_1708119265.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,091 F3 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:34 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-24-000043 · wk-form4_1708119265.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,635 F1 · shares: Payout under performance shares awarded at beginning of three-year (2021-2023) performance period. F2 · balance_after: Includes 122 units credited since December 1, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| February 14, 2024 Filed Feb 21, 2024 21:03 UTC Amendment | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 571 | $82.12 | $46,890.52 |
DisclosureSEC source: 0000915389-24-000058 · wk-form4a_1708549400.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,064 F1 · shares: This amendment corrects the Form 4 filed on February 16, 2024 with respect to the number of shares of common stock withheld in payment of tax liability incident to the payout of performance shares for the 2021-2023 performance period. The balance of shares beneficially owned following the reported transaction has also been corrected. F1 · balance_after: This amendment corrects the Form 4 filed on February 16, 2024 with respect to the number of shares of common stock withheld in payment of tax liability incident to the payout of performance shares for the 2021-2023 performance period. The balance of shares beneficially owned following the reported transaction has also been corrected. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionRestricted Stock Units · Derivative | 5,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000915389-23-000174 · wk-form4_1701723727.xml · derivative · entry 3 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,062 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · derivative.exercise_date: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · derivative.expiration_date: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 1,233 | $85.46 | $105,372.18 |
DisclosureSEC source: 0000915389-23-000174 · wk-form4_1701723727.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,339 F3 · shares: Shares of common stock withheld in satisfaction of tax liability upon vesting of the 5,062 restricted stock units. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 5,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000915389-23-000174 · wk-form4_1701723727.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F2 · balance_after: Includes 275 units credited since February 15, 2023 as hypothetical reinvestment of dividend equivalents. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 17,059 | $0.00 Strike: $83.84 | $0.00 |
DisclosureSEC source: 0000915389-23-000045 · wf-form4_167761829243668.xml · derivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,059 Underlying: Common Stock · 17,059 shares Expires 2033-02-23 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 24, 2024, February 24, 2025, and February 24, 2026, respectively. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 904 | $89.09 | $80,537.36 |
DisclosureSEC source: 0000915389-23-000025 · wf-form4_167666790611152.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,235 F3 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 3,631 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-23-000025 · wf-form4_167666790611152.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,139 F1 · shares: Payout under performance shares awarded at beginning of three-year (2020-2022) performance period. F2 · balance_after: Includes 59 shares acquired since October 17, 2022 resulting from automatic reinvestment of dividends. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionRestricted Stock Units · Derivative | 1,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033737 · doc4.xml · derivative · entry 3 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,715 shares Expires 2022-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · derivative.exercise_date: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F1 · derivative.expiration_date: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 675 | $73.94 | $49,909.50 |
DisclosureSEC source: 0000899243-22-033737 · doc4.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,449 F3 · shares: Shares of common stock withheld in satisfaction of tax liability upon vesting of the 1,715 restricted stock units. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 1,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033737 · doc4.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Payout of shares underlying restricted stock units upon satisfaction of time vesting condition. F2 · balance_after: Includes 99 shares acquired since February 23, 2022 resulting from automatic reinvestment of dividends. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 13:31 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 14,529 | $0.00 Strike: $120.80 | $0.00 |
DisclosureSEC source: 0000899243-22-008270 · doc4.xml · derivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,529 Underlying: Common Stock · 14,529 shares Expires 2032-02-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 25, 2023, February 25, 2024, and February 25, 2025, respectively. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 16:48 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 986 | $119.03 | $117,363.58 |
DisclosureSEC source: 0000899243-22-007831 · doc4.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,310 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout under performance shares. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 16:48 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 4,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-007831 · doc4.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,296 F1 · shares: Payout under performance shares awarded at beginning of three-year (2019-2021) performance period. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,420 | $0.00 Strike: $72.92 | $0.00 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · derivative · entry 9 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,869 Underlying: Common Stock · 3,420 shares Expires 2029-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the option became exercisable on October 15, 2020 and October 15, 2021, respectively, and one-third of the option becomes exercisable on October 15, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,840 | $0.00 Strike: $82.69 | $0.00 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · derivative · entry 8 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,420 Underlying: Common Stock · 4,840 shares Expires 2029-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-third of the option became exercisable on February 28, 2020 and February 28, 2021, respectively, and one-third of the option becomes exercisable on Februrary 28, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,478 | $0.00 Strike: $104.21 | $0.00 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · derivative · entry 7 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,478 shares Expires 2028-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 3,420 | $122.73 | $419,736.60 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 6 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,249 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 3,420 | $72.92 | $249,386.40 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 5 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 4,840 | $122.77 | $594,206.80 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 4 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,249 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 4,840 | $82.69 | $400,219.60 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 3 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 6,478 | $122.75 | $795,174.50 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 2 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,249 Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:38 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 6,478 | $104.21 | $675,072.38 |
DisclosureSEC source: 0000899243-22-005835 · doc4.xml · nonDerivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Jun 26, 2023 20:01 UTC Amendment | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,420 | $0.00 Strike: $72.92 | $0.00 |
DisclosureSEC source: 0000915389-23-000128 · wk-form4a_1687809699.xml · derivative · entry 1 Killian Christopher Moore · CIK 0001866834 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 3,420 shares Expires 2029-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Form 4 filed on February 11, 2022 incorrectly reported Item 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) as 6,869. The correct balance should be 3,440. This Amendment is filed to correct this balance only. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.